Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Durbin Bill Would Narrow Definition Of Dietary Supplement

This article was originally published in The Tan Sheet

Executive Summary

Legislation Sen. Dick Durbin offers to stop firms from allegedly side-stepping food safety standards by labeling products as dietary supplements could have a "devastating impact on the industry," stakeholders say.

You may also be interested in...



State Enforcement Needed On Weight Loss, Bodybuilding Supplements – Study

“The lax federal regulatory scheme for dietary supplements leaves extreme gaps in federal oversight that should be filled by state governments,” according to a report by public health experts. State attorneys general have “bully pulpit” to expand on enforcement authorities exercised by both FDA and FTC, they say.

State Enforcement Needed On Weight Loss, Bodybuilding Supplements – Study

“The lax federal regulatory scheme for dietary supplements leaves extreme gaps in federal oversight that should be filled by state governments,” according to a report by public health experts. State attorneys general have “bully pulpit” to expand on enforcement authorities exercised by both FDA and FTC, they say.

Pay Now For Better Supplement Industry Enforcement, Or Foot Higher Bill Later

By considering and addressing potential regulatory changes, the industry more likely can help shape changes and avoid greater regulatory burden such as pre-market review, suggests CRN President Steve Mister. User fees are an “issue that the industry is going to have to start looking at.”

Related Content

Topics

UsernamePublicRestriction

Register

PS105147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel